Inventor · disambiguated record
Thomas E. Rogers
Also filed as: ROGERS JAMES G · ROGERS THOMAS · ROGERS THOMAS E · ROGERS THOMAS EDWARD
56 granted patents·24 pending applications·1,896 citations·filing 1977–2023
98Inventor score
Top patents by PatentIndex Score
80 records- 0197US5134066AImproved probes using nucleosides containing 3-dezauracil analogsMONSANTO CO·Filed 1989·Granted Jul 28, 1992·1.4k cites·25 claims
- 0294US5344957ASubstituted β-amino acid derivatives useful as platelet aggregation inhibitorsSEARLE & CO·Filed 1992·Granted Sep 6, 1994·42 cites·18 claims
- 0391US4568432AProcess for preparing glyphosate and glyphosate derivativesMONSANTO CO·Filed 1984·Granted Feb 4, 1986·28 cites·21 claims
- 0490US5239113ASubstituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereofMONSANTO CO·Filed 1992·Granted Aug 24, 1993·27 cites·2 claims
- 0588US11160880B2Compositions and methods for assessing eye vasculatureMEDIBEACON INC·Filed 2019·Granted Nov 2, 2021·2 cites·15 claims
- 0685USD544941SCollapsible structureROGERS THOMAS EDWARD·Filed 2005·Granted Jun 19, 2007·38 cites·1 claims
- 0785US5254573ASubstituted heterocyclic derivatives useful as platelet aggregation inhibitorsMONSANTO CO·Filed 1992·Granted Oct 19, 1993·26 cites·26 claims
- 0884US7569572B2Pyrazolo[4,3-D]pyrimidinesPFIZER·Filed 2005·Granted Aug 4, 2009·10 cites·18 claims
- 0983US8871189B2MMP-targeted therapeutic and/or diagnostic nanocarriersMALLINCKRODT LLC·Filed 2012·Granted Oct 28, 2014·5 cites·35 claims
- 1083US6689754B1Heterocyclic glycyl β-alanine derivativesSEARLE & CO·Filed 1999·Granted Feb 10, 2004·28 cites·15 claims
- 1182US10898591B2Compositions and methods for assessing eye vasculatureMEDIBEACON INC·Filed 2019·Granted Jan 26, 2021·2 cites·12 claims
- 1282US5703125ASubstituted β-amino acid derivatives useful as platelet aggregation inhibitorsSEARLE & CO·Filed 1995·Granted Dec 30, 1997·17 cites·10 claims
- 1381US10525149B2Compositions and methods for assessing eye vasculatureMEDIBEACON INC·Filed 2016·Granted Jan 7, 2020·2 cites·38 claims
- 1481US6531494B1Gem-substituted αvβ3 antagonistsPHARMACIA CORP·Filed 2001·Granted Mar 11, 2003·10 cites·15 claims
- 1580US6013651AMeta-azacyclic amino benzoic acid compounds and derivatives thereofSEARLE & CO·Filed 1998·Granted Jan 11, 2000·23 cites·36 claims
- 1680US5952381APara-substituted phenylene derivativesSEARLE & CO·Filed 1997·Granted Sep 14, 1999·44 cites·28 claims
- 1780US4457813AElectrolysis cells and electrolytic processesMONSANTO CO·Filed 1983·Granted Jul 3, 1984·26 cites·10 claims
- 1879US6100423AAmino benzenepropanoic acid compounds and derivatives thereofSEARLE & CO·Filed 1999·Granted Aug 8, 2000·21 cites·3 claims
- 1978US6808877B2Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infectionUS HEALTH·Filed 2002·Granted Oct 26, 2004·11 cites·9 claims
- 2077US6028223AMeta-guanidine, urea, thiourea or azacyclic amino benzoic acid compounds and derivatives thereofSEARLE & CO·Filed 1996·Granted Feb 22, 2000·39 cites·36 claims
- 2175US12303570B2Compositions and methods for assessing eye vasculatureMEDIBEACON INC·Filed 2021·Granted May 20, 2025·0 cites·31 claims
- 2275US6921767B2Cycloalkyl alkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2002·Granted Jul 26, 2005·9 cites·2 claims
- 2372US5378727ASubstituted bicyclic heterocyclic compounds useful as platelet aggregation inhibitorsSEARLE & CO·Filed 1993·Granted Jan 3, 1995·11 cites·25 claims
- 2470US9216225B2Remote assembly of targeted nanoparticles using H-phosphate ENE/-YNE hydrophosphonylation reactionsROGERS THOMAS E·Filed 2012·Granted Dec 22, 2015·2 cites·8 claims
- 2569US6720327B2Lactone integrin antagonistsPHARMACIA CORP·Filed 2001·Granted Apr 13, 2004·4 cites·5 claims
- 2669US2023173111A1Compositions and systems for renal function determinationMEDIBEACON INC·Filed 2023·Application pending·0 cites
- 2769US2023158175A1Methods for renal function determinationMEDIBEACON INC·Filed 2023·Application pending·0 cites
- 2868US6949578B2Cycloalkyl alkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2004·Granted Sep 27, 2005·3 cites·27 claims
- 2968US6900232B2Cycloalkyl alkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted May 31, 2005·3 cites·65 claims
- 3067US2024182430A1Synthesis of substituted pyrazinesMEDIBEACON INC·Filed 2023·Application pending·0 cites
- 3166US11602570B2Compositions and systems for renal function determinationMEDIBEACON INC·Filed 2018·Granted Mar 14, 2023·0 cites·60 claims
- 3265US11590244B2Methods for renal function determinationMEDIBEACON INC·Filed 2018·Granted Feb 28, 2023·0 cites·38 claims
- 3365US2015004097A1Mmp-targeted therapeutic and/or diagnostic nanocarriersMALLINCKRODT LLC·Filed 2014·Application pending·0 cites
- 3465US2019192694A1Compositions and methods for assessing eye vasculatureMEDIBEACON INC·Filed 2019·Application pending·0 cites
- 3565US2015030541A1Nanoparticle peg modification with h-phosphonatesMALLINCKRODT LLC·Filed 2014·Application pending·0 cites
- 3664US11708336B2Anodic oxidation of 5-aminouracilMEDIBEACON INC·Filed 2020·Granted Jul 25, 2023·0 cites·14 claims
- 3763US6833366B1Dihydrostilbene alkanoic acid derivativesPHARMACIA CORP·Filed 2003·Granted Dec 21, 2004·1 cites·16 claims
- 3862US6906051B2Lactone integrin antagonistsPHARMACIA CORP·Filed 2003·Granted Jun 14, 2005·2 cites·12 claims
- 3962US6372719B1ανβ3 integrin antagonists in combination with chemotherapeutic agentsFiled 1999·Granted Apr 16, 2002·20 cites·13 claims
- 4058US12319660B2Preparation of substituted diaminopyrazine dicarboxylic acidsMEDIBEACON INC·Filed 2022·Granted Jun 3, 2025·0 cites·26 claims
- 4157US12428382B2Purification of substituted diaminopyrazine dicarboxylic acidsMEDIBEACON INC·Filed 2022·Granted Sep 30, 2025·0 cites·30 claims
- 4257US2022143222A1Subcutaneous and intramuscular administration of pyrazine compoundsMEDIBEACON INC·Filed 2021·Application pending·0 cites
- 4356US2024182551A1Cross-reactive monoclonal antibodies against coronavirusesSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 4455US2024025864A1Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereofHANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4553US5489594APlatelet aggregation inhibitorsSEARLE & CO·Filed 1995·Granted Feb 6, 1996·4 cites·10 claims
- 4653US2004209897A1Mitogen activated protein kinase-activated protein kinase-2 inhibiting compoundsPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 4752US6251944B1Para-substituted phenylene derivativesSEARLE & CO·Filed 1999·Granted Jun 26, 2001·9 cites·30 claims
- 4849US2004005354A1Oral trimethobenzamide formulations and methodsKING PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4949US2014234217A1Remote assembly of targeted nanoparticles using complementary oligonucleotide linkersMALLINCKRODT LLC·Filed 2012·Application pending·0 cites
- 5049US2004127477A1Heterocyclic glycyl beta-alanine derivativesSEARLE & CO·Filed 2003·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas E. Rogers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →